The global BCG Vaccine for Tuberculosis (TB) market size is predicted to grow from US$ 80.8 million in 2025 to US$ 97 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.

Key driver for the BCG vaccine market is the increasing prevalence of tuberculosis (TB) in various regions, especially in countries with lower healthcare resources. Rising TB cases have driven governments and global health organizations, like the World Health Organization (WHO), to actively promote TB vaccination programs to curb the spread of the disease. Efforts to increase BCG vaccine coverage in high-risk areas and the focus on reducing childhood TB have further propelled demand, creating a sustained need for vaccine supply and development.

A major challenge in the BCG vaccine market is the variability in its effectiveness, especially against pulmonary TB in adults. This inconsistency in protection levels has led to cautious adoption in some regions with lower TB rates. Moreover, the emergence of multi-drug-resistant TB strains complicates the market, as BCG is not effective against these resistant strains. These limitations emphasize the need for alternative vaccines or treatments, affecting the long-term outlook for BCG as a standalone solution in TB prevention.

Infinity Market Research newest research report, the ?BCG Vaccine for Tuberculosis (TB) Industry Forecast? looks at past sales and reviews total world BCG Vaccine for Tuberculosis (TB) sales in 2024, providing a comprehensive analysis by region and market sector of projected BCG Vaccine for Tuberculosis (TB) sales for 2025 through 2031. With BCG Vaccine for Tuberculosis (TB) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine for Tuberculosis (TB) industry.

This Insight Report provides a comprehensive analysis of the global BCG Vaccine for Tuberculosis (TB) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine for Tuberculosis (TB) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global BCG Vaccine for Tuberculosis (TB) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine for Tuberculosis (TB) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine for Tuberculosis (TB).

This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine for Tuberculosis (TB) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Immune Type
    Therapy Type

Segmentation by Application:

    Hospitals
    Clinics
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Merck
    Japan BCG Lab
    China National Biotec
    AJ Vaccines
    Serum Institute of India
    BioFarma
    GSBPL
    Biomed Lublin
    Taj Pharmaceuticals
    Ataulpho de Paiva
    ANLIS Malbran
    Funda?o Ataulpho de Paiva
    BB-NCIPD
    Torlakinstitut
    IVAC?InstituteofVaccinesandMedicalBiologicals
    Institut Pasteur de Tunis

Key Questions Addressed in this Report

What is the 10-year outlook for the global BCG Vaccine for Tuberculosis (TB) market?
What factors are driving BCG Vaccine for Tuberculosis (TB) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG Vaccine for Tuberculosis (TB) market opportunities vary by end market size?
How does BCG Vaccine for Tuberculosis (TB) break out by Type, by Application?